BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29611200)

  • 1. Assessment of pre-operative maropitant citrate use in macaque (Macaca fasicularis & Macaca mulatta) neurosurgical procedures.
    Steinbach JR; MacGuire J; Chang S; Dierks E; Roble GS
    J Med Primatol; 2018 Jun; 47(3):178-184. PubMed ID: 29611200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of single doses of maropitant citrate in adult horses.
    Berryhill EH; Knych H; Edman JM; Magdesian KG
    J Vet Pharmacol Ther; 2019 Jul; 42(4):487-491. PubMed ID: 31190332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of refrigeration of the antiemetic Cerenia (maropitant) on pain on injection.
    Narishetty ST; Galvan B; Coscarelli E; Aleo M; Fleck T; Humphrey W; McCall RB
    Vet Ther; 2009; 10(3):93-102. PubMed ID: 20037963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of maropitant citrate or acepromazine on the incidence of adverse events associated with hydromorphone premedication in dogs.
    Claude AK; Dedeaux A; Chiavaccini L; Hinz S
    J Vet Intern Med; 2014; 28(5):1414-7. PubMed ID: 25146756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maropitant administered orally 2-2.5 h prior to morphine and dexmedetomidine reduces the incidence of emesis in cats.
    Martin-Flores M; Mastrocco A; Lorenzutti AM; Campoy L; Kirch P; Stone M; Learn MM; Boesch JM
    J Feline Med Surg; 2017 Aug; 19(8):876-879. PubMed ID: 27538868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of maropitant citrate after oral administration of multiple doses in adult horses.
    Berryhill EH; Knych H; Chigerwe M; Edman J; Magdesian KG
    J Vet Pharmacol Ther; 2020 May; 43(3):282-287. PubMed ID: 32067245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats.
    Hickman MA; Cox SR; Mahabir S; Miskell C; Lin J; Bunger A; McCall RB
    J Vet Pharmacol Ther; 2008 Jun; 31(3):220-9. PubMed ID: 18471143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
    Kenward H; Elliott J; Lee T; Pelligand L
    BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of maropitant citrate dosed orally to dogs at 2 mg/kg and 8 mg/kg once daily for 14 days consecutive days.
    Lesman SP; Boucher JF; Grover GS; Cox SR; Bidgood TL
    J Vet Pharmacol Ther; 2013 Oct; 36(5):462-70. PubMed ID: 23167698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of maropitant on intraoperative isoflurane requirements and postoperative nausea and vomiting in dogs: a randomized clinical trial.
    Swallow A; Rioja E; Elmer T; Dugdale A
    Vet Anaesth Analg; 2017 Jul; 44(4):785-793. PubMed ID: 28844293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of maropitant citrate in Rhode Island Red chickens (Gallus gallus domesticus) following subcutaneous administration.
    Mones AB; Petritz OA; Knych HK; Sadar MJ; Thomson AE; Guzman DS
    J Vet Pharmacol Ther; 2022 Sep; 45(5):495-500. PubMed ID: 35734891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs.
    Hay Kraus BL
    J Am Vet Med Assoc; 2014 May; 244(10):1164-9. PubMed ID: 24786163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs.
    Benchaoui HA; Cox SR; Schneider RP; Boucher JF; Clemence RG
    J Vet Pharmacol Ther; 2007 Aug; 30(4):336-44. PubMed ID: 17610407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.
    de la Puente-Redondo VA; Siedek EM; Benchaoui HA; Tilt N; Rowan TG; Clemence RG
    J Small Anim Pract; 2007 Feb; 48(2):93-8. PubMed ID: 17286662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intramuscular maropitant in pigs (Sus scrofa domesticus).
    Smith JS; Gebert JE; Ebner LS; Bennett KO; Collins RJ; Hampton CE; Kleine SA; Mulon PY; Smith CK; Seddighi R; Bussieres G; Mochel JP; Knych HK
    J Vet Pharmacol Ther; 2023 May; 46(3):158-164. PubMed ID: 36872454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model.
    de la Puente-Redondo V; Tingley FD; Schneider RP; Hickman MA
    J Vet Pharmacol Ther; 2007 Aug; 30(4):281-7. PubMed ID: 17610400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilution of maropitant (Cerenia) in lactated Ringer solution prolongs subcutaneous drug absorption and reduces maximum plasma concentration.
    Yee DE; Ochigbo G; Menard J; Rosa BV
    J Am Vet Med Assoc; 2023 Aug; 261(8):1160-1165. PubMed ID: 36884379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of maropitant in cats receiving dexmedetomidine and morphine.
    Martin-Flores M; Sakai DM; Learn MM; Mastrocco A; Campoy L; Boesch JM; Gleed RD
    J Am Vet Med Assoc; 2016 Jun; 248(11):1257-61. PubMed ID: 27172341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of maropitant, acepromazine, and electroacupuncture on vomiting associated with administration of morphine in dogs.
    Koh RB; Isaza N; Xie H; Cooke K; Robertson SA
    J Am Vet Med Assoc; 2014 Apr; 244(7):820-9. PubMed ID: 24649993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the antiemetic efficacy of maropitant in dogs medicated with morphine and acepromazine.
    Lorenzutti AM; Martín-Flores M; Litterio NJ; Himelfarb MA; Zarazaga MP
    Vet Anaesth Analg; 2016 Mar; 43(2):195-8. PubMed ID: 26095960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.